BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8624374)

  • 1. Minimally differentiated acute myeloid leukemia (AML-M0): a distinct clinico-biologic entity with poor prognosis.
    Amadori S; Venditti A; Del Poeta G; Stasi R; Buccisano F; Bruno A; Tamburini A; Cox MC; Maffei L; Aronica G; Simone MD; Adorno G; Masi M; Tribalto M; Papa G
    Ann Hematol; 1996 Apr; 72(4):208-15. PubMed ID: 8624374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes.
    Venditti A; Del Poeta G; Buccisano F; Tamburini A; Cox MC; Stasi R; Bruno A; Aronica G; Maffei L; Suppo G; Simone MD; Forte L; Cordero V; Postorino M; Tufilli V; Isacchi G; Masi M; Papa G; Amadori S
    Blood; 1997 Jan; 89(2):621-9. PubMed ID: 9002966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.
    Suzuki R; Murata M; Kami M; Ohtake S; Asou N; Kodera Y; Tomonaga M; Masaki Y; Kusumoto S; Takeuchi J; Matsuda S; Hirai H; Yorimitsu mS; Hamajima N; Seto M; Shimoyama M; Ohno R; Morishima Y; Nakamura S
    Int J Hematol; 2003 Jun; 77(5):482-9. PubMed ID: 12841387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloblastic leukemia with minimal myeloid differentiation: phenotypical and ultrastructural characteristics.
    Villamor N; Zarco MA; Rozman M; Ribera JM; Feliu E; Montserrat E
    Leukemia; 1998 Jul; 12(7):1071-5. PubMed ID: 9665192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors.
    Costello R; Mallet F; Chambost H; Sainty D; Arnoulet C; Gastaut JA; Olive D
    Leukemia; 1999 Oct; 13(10):1513-8. PubMed ID: 10516751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of treatment failure in patients with minimally differentiated acute myeloid leukemia (AML-M0).
    Stasi R; Del Poeta G; Venditti A; Masi M; Stipa E; Dentamaro T; Cox C; Dallapiccola B; Papa G
    Blood; 1994 Mar; 83(6):1619-25. PubMed ID: 8123853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings.
    Cuneo A; Ferrant A; Michaux JL; Boogaerts M; Demuynck H; Van Orshoven A; Criel A; Stul M; Dal Cin P; Hernandez J
    Blood; 1995 Jun; 85(12):3688-94. PubMed ID: 7780152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally differentiated acute myeloid leukemia (AML M0): clinico-biological findings of 29 cases.
    Cascavilla N; Melillo L; D'Arena G; Greco MM; Carella AM; Sajeva MR; Perla G; Matera R; Minervini MM; Carotenuto M
    Leuk Lymphoma; 2000 Mar; 37(1-2):105-13. PubMed ID: 10721774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of myeloperoxidase gene expression in minimally differentiated acute myelogenous leukemia (AML-M0) using in situ hybridization.
    Traweek ST; Liu J; Braziel RM; Johnson RM; Byrnes RK
    Diagn Mol Pathol; 1995 Sep; 4(3):212-9. PubMed ID: 7493141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally differentiated acute myeloid leukemia in Taiwan: predominantly occurs in children less than 3 years and adults between 51 and 70 years.
    Huang SY; Tang JL; Jou ST; Tsay W; Hu CH; Lin DT; Lin KS; Lin KS; Wang CH; Chen YC; Shen MC; Tien HF
    Leukemia; 1999 Oct; 13(10):1506-12. PubMed ID: 10516750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0).
    Kotylo PK; Seo IS; Smith FO; Heerema NA; Fineberg NS; Miller K; Greene ME; Chou P; Orazi A
    Am J Clin Pathol; 2000 Feb; 113(2):193-200. PubMed ID: 10664621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
    Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
    Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of minimally differentiated acute myeloid leukemia: M0 is a distinct entity subdivided by RUNX1 mutation status.
    Silva FP; Swagemakers SM; Erpelinck-Verschueren C; Wouters BJ; Delwel R; Vrieling H; van der Spek P; Valk PJ; Giphart-Gassler M
    Blood; 2009 Oct; 114(14):3001-7. PubMed ID: 19666867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
    Lewis RE; Cruse JM; Webb RN; Sanders CM; Beason K
    Exp Mol Pathol; 2007 Oct; 83(2):269-73. PubMed ID: 17603036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between immunological characteristics and prognosis in children with acute myeloid leukemia].
    Gu LJ; Tie LJ; Jiang LM; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP; Ye H
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):241-5. PubMed ID: 19374802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.